Tarek Hammoud - Mar 24, 2023 Form 4 Insider Report for Enfusion, Inc. (ENFN)

Role
10%+ Owner
Signature
/s/ Tarek Hammoud
Stock symbol
ENFN
Transactions as of
Mar 24, 2023
Transactions value $
$0
Form type
4
Date filed
3/28/2023, 04:30 PM
Previous filing
Mar 10, 2023
Next filing
Jul 13, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ENFN Class A Common Stock Conversion of derivative security +1M +259067.36% 1M Mar 24, 2023 See footnote F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ENFN Common Units of Enfusion Ltd. LLC Conversion of derivative security $0 -1M -11.11% $0.00 8M Mar 24, 2023 Class A Common Stock 1M See Footnote F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Common Units of Enfusion Ltd. LLC, and the corresponding shares of Class B common stock are exchangeable for shares of the issuer's Class A common stock on a one-for-one basis with the issuer having the ability to elect to pay cash in lieu of issuing Class A common stock.
F2 These Common Units are held by LRA Ventures, LLC. Tarek Hammoud is the sole manager of LRA Ventures, LLC, an estate planning vehicle. Mr. Hammoud may be deemed to have dispositive power over the securities held by LRA Ventures, LLC. Mr. Hammoud disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.